Combined Opioid-NMDA Antagonist Therapies
- 1 January 1998
- journal article
- review article
- Published by Springer Nature in Drugs
- Vol. 55 (1) , 1-4
- https://doi.org/10.2165/00003495-199855010-00001
Abstract
The potential beneficial effect of coadministration of opiates with antagonists of the N-methyl-D-aspartate (NMDA) receptor for glutamate are discussed. There is a growing body of experimental data...Keywords
This publication has 31 references indexed in Scilit:
- Ketamine Attenuates and Reverses Morphine Tolerance in RodentsAnesthesiology, 1996
- Oral administration of dextromethorphan prevents the development of morphine tolerance and dependence in ratsPain, 1996
- Comparison of morphine and morphine with ketamine for postoperative analgesiaCanadian Journal of Anesthesia/Journal canadien d'anesthésie, 1996
- Mechanisms of hyperalgesian and morphine tolerance: a current view of their possible interactionsPain, 1995
- Dextromethorphan attenuates and reverses analgesic tolerance to morphinePain, 1994
- The NMDA Receptor antagonists, LY274614 and MK-801, and the nitric oxide synthase inhibitor, NG-nitro-L-arginine, attenuate analgesic tolerance to the mu-opioid morphine but not to kappa opioidsPain, 1994
- Studies on the spinal interaction of morphine and the NMDA antagonist MK-801 on the hyperesthesia observed in a rat model of sciatic mononeuropathyNeuroscience Letters, 1992
- Sustained potentiation of NMDA receptor-mediated glutamate responses through activation of protein kinase C by a μ opioidNeuron, 1991
- The induction and maintenance of central sensitization is dependent onN-methyl-d-aspartic acid receptor activation; implications for the treatment of post-injury pain hypersensitivity statesPublished by Wolters Kluwer Health ,1991
- Inhibition of Morphine Tolerance and Dependence by the NMDA Receptor Antagonist MK-801Science, 1991